Results 21 to 30 of about 15,828 (290)
Cerebral ischemia following clipping of cerebral aneurysms constitutes major cause of morbidity and mortality. Clip-related injury to vessel, postoperative clip rotation, prolonged temporary occlusion, intraoperative rupture, and vasospasm are some ...
Chirag Jain+3 more
doaj +1 more source
Comparison of eptifibatide and abciximab with decision analysis [PDF]
Dorothy H. Wong
openalex +4 more sources
Quantitative structural mechanobiology of platelet-driven blood clot contraction. [PDF]
Blood clot contraction plays an important role in prevention of bleeding and in thrombotic disorders. Here, we unveil and quantify the structural mechanisms of clot contraction at the level of single platelets.
Alber, Mark S+3 more
core +2 more sources
New recommendations and opinions released in Chinese expert consensus on the diagnosis and treatment of coronary microvascular diseases—2023, as compared with Chinese expert consensus on the diagnosis and treatment of coronary microvascular diseases issued in 2017. Abstract Since the four working groups of the Chinese Society of Cardiology issued first
Wenqiang Chen+16 more
wiley +1 more source
Bilateral subconjunctival hemorrhage secondary to abciximab use: case report
CONTEXT: There are no reports on cases of subconjunctival hemorrhage due to use of glycoprotein IIb/IIIa inhibitors. In this report, we present the case of a patient with bilateral subconjunctival hemorrhage after receiving abciximab.
Selim Kul, Muhammet Raşit Sayın
doaj +1 more source
Cryo-Electron Microscopy Structure of the αIIbβ3-Abciximab Complex
Supplemental Digital Content is available in the text. Objective: The αIIbβ3 antagonist antiplatelet drug abciximab is the chimeric antigen-binding fragment comprising the variable regions of murine monoclonal antibody 7E3 and the constant domains of ...
D. Nesic+7 more
semanticscholar +1 more source
The Concise Guide to PHARMACOLOGY 2023/24: Catalytic receptors
The Concise Guide to PHARMACOLOGY 2023/24 is the sixth in this series of biennial publications. The Concise Guide provides concise overviews, mostly in tabular format, of the key properties of approximately 1800 drug targets, and nearly 6000 interactions with about 3900 ligands.
Stephen P. H. Alexander+27 more
wiley +1 more source
Background The significant reduction of angiographic restenosis rates in the ISAR-SWEET study (intracoronary stenting and antithrombotic regimen: is abciximab a superior way to eliminate elevated thrombotic risk in diabetes) raises the question of ...
Baur Regine+4 more
doaj +1 more source
Long-Term Results After the Glycoprotein IIb/IIIa Inhibitor Abciximab in Unstable Angina [PDF]
BACKGROUND: This study was designed to investigate long-term effects of the glycoprotein IIb/IIIa inhibitor abciximab in patients with acute coronary syndrome without ST elevation who were not scheduled for coronary intervention.
Armstrong, P.W. (Paul)+9 more
core +3 more sources
Viscoelastic testing: Critical appraisal of new methodologies and current literature
Abstract United States Food and Drug Administration (FDA)‐approved viscoelastic testing (VET) methodologies have significantly changed in the last 10 years, with the availability of cartridge‐based VET. Some of these cartridge‐based methodologies use harmonic resonance‐based clot detection.
Geoffrey D. Wool, Timothy Carll
wiley +1 more source